
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers.
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The agent is approved for use as a challenge agent in studies demonstrating the early efficacy of influenza drugs and vaccines.
Read the full release






